22q11.2 deletion syndrome (22q11.2DS) is a complex genetic disorder characterized by a wide range of comorbidities requiring multidisciplinary care across the lifespan. As patients transition from pediatric to adult care, they face significant challenges, particularly with managing emerging psychiatric conditions such as schizophrenia, anxiety, and depression, alongside ongoing medical concerns involving cardiology, endocrinology, immunology, and other specialties. However, there is a lack of standardized transition protocols specifically designed for individuals with 22q11.2DS, leaving both caregivers and healthcare providers frustrated by inadequate coordination and communication during this critical period. This review addresses these gaps by presenting a framework for transition planning, drawing on existing literature and clinical practices. A comprehensive review used PubMed, Embase, and Web of Science to explore topics such as healthcare transitions, neuropsychiatric and cognitive developments, education, employment, social-sexual health, and caregiver challenges. Based on the findings, specialty-specific resources were developed and refined through a multidisciplinary 22q11.2DS clinic team. These resources include transfer passports summarizing key medical information for adult providers, transition readiness assessments, and customized transition manuals. The proposed framework emphasizes early and ongoing preparation for transitions, collaboration among providers, and patient-centered care to promote independence. The goal is to equip families and healthcare professionals with practical tools and strategies to support seamless care continuity, improve outcomes, and address the complex needs of individuals with 22q11.2DS as they navigate adulthood. This work contributes to the growing body of knowledge on healthcare transitions and highlights the need for continued research and tailored guidelines for this population.
BlagojevicCHeungTTheriaultM, et al.Estimate of the contemporary live-birth prevalence of recurrent 22q11.2 deletions: A cross-sectional analysis from population-based newborn screening. CMAJ Open. 2021;9(3):E802–E809. doi:https://doi.org/10.9778/cmajo.20200294
2.
KerinLLynchDMcNicholasF. Participatory development of a patient-clinician communication tool to enhance healthcare transitions for young people with 22q11.2. Ir J Med Sci. 2020;189(3):761–769. doi:https://doi.org/10.1007/s11845-019-02104-6
3.
BootEÓskarsdóttirSLooJCY, et al.Updated clinical practice recommendations for managing adults with 22q11.2 deletion syndrome. Genet Med. 2023;25(3):100344. doi:https://doi.org/10.1016/j.gim.2022.11.012
4.
ÓskarsdóttirSBootECrowleyTB, et al.Updated clinical practice recommendations for managing children with 22q11.2 deletion syndrome. Genet Med. 2023;25(3):100338. doi:https://doi.org/10.1016/j.gim.2022.11.006
CampbellIMSheppardSECrowleyTB, et al.What is new with 22q? An update from the 22q and you center at the children's hospital of Philadelphia. Am J Med Genet A. 2018;176(10):2058–2069. doi:https://doi.org/10.1002/ajmg.a.40637
7.
MorrowBEMcDonald-McGinnDMEmanuelBSVermeeschJRScamblerPJ. Molecular genetics of 22q11.2 deletion syndrome. Am J Med Genet A. 2018;176(10):2070–2081. doi:https://doi.org/10.1002/ajmg.a.40504
8.
BusseTGrahamJMFeldmanG, et al.High-resolution genomic arrays identify CNVs that phenocopy the chromosome 22q11.2 deletion syndrome. Hum Mutat. 2011;32(1):91–97. doi:https://doi.org/10.1002/humu.21395
CohenJLCrowleyTBMcGinnDE, et al.22q and two: 22q11.2 deletion syndrome and coexisting conditions. Am J Med Genet A. 2018;176(10):2203–2214. doi:https://doi.org/10.1002/ajmg.a.40494
11.
BlagowidowNNowakowskaBSchindewolfE, et al.Prenatal screening and diagnostic considerations for 22q11.2 microdeletions. Genes (Basel). 2023;14(1):160. doi:https://doi.org/10.3390/genes14010160
12.
GoodwinJSwaabLCampbellLE. She'll be able to live independently… as long as I'm around": The “lived” experience of parenting a child with 22q11.2 deletion syndrome in the transition to adulthood. J Appl Res Intellect Disabil. 2020;33(3):565–573. doi:https://doi.org/10.1111/jar.12700
13.
KarasDJCostainGChowEWCBassettAS. Perceived burden and neuropsychiatric morbidities in adults with 22q11.2 deletion syndrome. J Intellect Disabil Res. 2014;58(2):198–210. doi:https://doi.org/10.1111/j.1365-2788.2012.01639.x
14.
GadanchevaVMolloyEMcNicholasF. Transition from paediatric to adult services for patients with 22q11.2 deletion syndrome. Ir Med J. 2023;116(1):5.
15.
ButcherNJChowEWCCostainGKarasDHoABassettAS. Functional outcomes of adults with 22q11.2 deletion syndrome. Genet Med. 2012;14(10):836–843. doi:https://doi.org/10.1038/gim.2012.66
16.
Van de WoestyneKVandensandeAVansteelandtKMaesBVergaelenESwillenA. Resilience and quality of life in young adults with a 22q11.2 deletion syndrome: A patient's perspective. Eur Child Adolesc Psychiatry. 2022;31(12):1885–1894. doi:https://doi.org/10.1007/s00787-021-01822-6
17.
NiarchouMChawnerSAFiksinskiA, et al.Attention deficit hyperactivity disorder symptoms as antecedents of later psychotic outcomes in 22q11.2 deletion syndrome. Schizophr Res. 2019;204:320–325. doi:https://doi.org/10.1016/j.schres.2018.07.044
18.
FiksinskiAMBreetveltEJDuijffSNBassettASKahnRSVorstmanJAS. Autism spectrum and psychosis risk in the 22q11.2 deletion syndrome. Findings from a prospective longitudinal study. Schizophr Res. 2017;188:59–62. doi:https://doi.org/10.1016/j.schres.2017.01.032
19.
BassettASChowEWCAbdelMalikPGheorghiuMHustedJWeksbergR. The schizophrenia phenotype in 22q11 deletion syndrome. Am J Psychiatry. 2003;160(9):1580–1586. doi:https://doi.org/10.1176/appi.ajp.160.9.1580
20.
FungWLAMcEvillyRFongJSilversidesCChowEBassettA. Elevated prevalence of generalized anxiety disorder in adults with 22q11.2 deletion syndrome. Am J Psychiatry. 2010;167(8):998. doi:https://doi.org/10.1176/appi.ajp.2010.09101463
21.
SchneiderMDebbanéMBassettAS, et al.Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: Results from the international consortium on brain and behavior in 22q11.2 deletion syndrome. Am J Psychiatry. 2014;171(6):627–639. doi:https://doi.org/10.1176/appi.ajp.2013.13070864
22.
DufournetBNguyenKCharlesP, et al.Parkinson's disease associated with 22q11.2 deletion: Clinical characteristics and response to treatment. Rev Neurol (Paris). 2017;173(6):406–410. doi:https://doi.org/10.1016/j.neurol.2017.03.021
23.
MauroJDiazMCórdovaT, et al.Analysis of REM sleep without atonia in 22q11.2 deletion syndrome determined by domiciliary polysomnography: A cross sectional study. Sleep. 2022;45(2):zsab300. doi:https://doi.org/10.1093/sleep/zsab300
24.
BuckleyESiddiqueAMcNeillA. Hyposmia, symptoms of rapid eye movement sleep behavior disorder, and parkinsonian motor signs suggest prodromal neurodegeneration in 22q11 deletion syndrome. Neuroreport. 2017;28(11):677–681. doi:https://doi.org/10.1097/WNR.0000000000000815
25.
PalmerLDHeungTCorralMBootEBrooksSGBassettAS. Sexual knowledge and behaviour in 22q11.2 deletion syndrome, a complex care condition. J Appl Res Intellect Disabil. 2022;35(4):966–975. doi:https://doi.org/10.1111/jar.12927
26.
FungWLAButcherNJCostainG, et al.Practical guidelines for managing adults with 22q11.2 deletion syndrome. Genet Med. 2015;17(8):599–609. doi:https://doi.org/10.1038/gim.2014.175
27.
BassettASMcDonald-McGinnDMDevriendtK, et al.Practical guidelines for managing patients with 22q11.2 deletion syndrome. J Pediatr. 2011;159(2):332–339.e1. doi:https://doi.org/10.1016/j.jpeds.2011.02.039
28.
BaumgartnerHDe BackerJBabu-NarayanSV, et al.2020 ESC guidelines for the management of adult congenital heart disease. Eur Heart J. 2021;42(6):563–645. doi:https://doi.org/10.1093/eurheartj/ehaa554
29.
KauwDWoudstraOIvan EngelenK, et al.22q11.2 deletion syndrome is associated with increased mortality in adults with tetralogy of Fallot and pulmonary atresia with ventricular septal defect. Int J Cardiol. 2020;306:56–60. doi:https://doi.org/10.1016/j.ijcard.2020.02.064
30.
de RinaldisCPButenskyAPatelS, et al.Aortic root dilation in patients with 22q11.2 deletion syndrome without intracardiac anomalies. Pediatr Cardiol. 2021;42(7):1594–1600. doi:https://doi.org/10.1007/s00246-021-02645-7
31.
JohnASMcDonald-McGinnDMZackaiEHGoldmuntzE. Aortic root dilation in patients with 22q11.2 deletion syndrome. Am J Med Genet A. 2009;149A(5):939–942. doi:https://doi.org/10.1002/ajmg.a.32770
32.
UnoltMVersacciPAnaclerioS, et al.Congenital heart diseases and cardiovascular abnormalities in 22q11.2 deletion syndrome: From well-established knowledge to new frontiers. Am J Med Genet A. 2018;176(10):2087–2098. doi:https://doi.org/10.1002/ajmg.a.38662
33.
WilsonWRGewitzMLockhartPB, et al.Prevention of Viridans group streptococcal infective endocarditis: A scientific statement from the American Heart Association. Circulation. 2021;143(20):e963–e978. doi:https://doi.org/10.1161/CIR.0000000000000969
34.
BassettASChowEWCHustedJ, et al.Clinical features of 78 adults with 22q11 deletion syndrome. Am J Med Genet A. 2005;138(4):307–313. doi:https://doi.org/10.1002/ajmg.a.30984
35.
KaoAMarianiJMcDonald-McGinnDM, et al.Increased prevalence of unprovoked seizures in patients with a 22q11.2 deletion. Am J Med Genet A. 2004;129A(1):29–34. doi:https://doi.org/10.1002/ajmg.a.30133
36.
WitherRGBorlotFMacDonaldA, et al.22q11.2 deletion syndrome lowers seizure threshold in adult patients without epilepsy. Epilepsia. 2017;58(6):1095–1101. doi:https://doi.org/10.1111/epi.13748
37.
ButcherNJKiehlTHazratiL, et al.Association between early-onset Parkinson disease and 22q11.2 deletion syndrome: Identification of a novel genetic form of Parkinson disease and its clinical implications. JAMA Neurol. 2013;70(11):1359–1366. doi:https://doi.org/10.1001/jamaneurol.2013.3646
38.
PerssonCFrimanVÓskarsdóttirSJönssonR. Speech and hearing in adults with 22q11.2 deletion syndrome. Am J Med Genet A. 2012;158A(12):3071–3079. doi:https://doi.org/10.1002/ajmg.a.35589
39.
de ReuverSHomansJFSchlösserTPC, et al.22q11.2 deletion syndrome as a human model for idiopathic scoliosis. J Clin Med. 2021;10(21):4823. doi:https://doi.org/10.3390/jcm10214823
40.
HomansJFBaldewVGMBrinkRC, et al.Scoliosis in association with the 22q11.2 deletion syndrome: An observational study. Arch Dis Child. 2019;104(1):19–24. doi:https://doi.org/10.1136/archdischild-2018-314779
41.
Van BataviaJPCrowleyTBBurrowsE, et al.Anomalies of the genitourinary tract in children with 22q11.2 deletion syndrome. Am J Med Genet A. 2019;179(3):381–385. doi:https://doi.org/10.1002/ajmg.a.61020
42.
Lopez-RiveraELiuYPVerbitskyM, et al.Genetic drivers of kidney defects in the DiGeorge syndrome. N Engl J Med. 2017;376(8):742–754. doi:https://doi.org/10.1056/NEJMoa1609009
43.
BjörkAHÓskarsdóttirSAnderssonBAFrimanV. Antibody deficiency in adults with 22q11.2 deletion syndrome. Am J Med Genet A. 2012;158A(8):1934–1940. doi:https://doi.org/10.1002/ajmg.a.35484
44.
CheungENMGeorgeSRCostainGA, et al.Prevalence of hypocalcaemia and its associated features in 22q11·2 deletion syndrome. Clin Endocrinol (Oxf). 2014;81(2):190–196. doi:https://doi.org/10.1111/cen.12466
45.
LimaKAbrahamsenTGWolffAB, et al.Hypoparathyroidism and autoimmunity in the 22q11.2 deletion syndrome. Eur J Endocrinol. 2011;165(2):345–352. doi:https://doi.org/10.1530/EJE-10-1206
46.
DaviesKStiehmERWooPMurrayKJ. Juvenile idiopathic polyarticular arthritis and IgA deficiency in the 22q11 deletion syndrome. J Rheumatol. 2001;28(10):2326–2334.
47.
KatoTKosakaKKimuraM, et al.Thrombocytopenia in patients with 22q11.2 deletion syndrome and its association with glycoprotein Ib-beta. Genet Med. 2003;5(2):113–119. doi:https://doi.org/10.1097/01.GIM.0000056828.03164.30
48.
McDonald-McGinnDMReillyAWallgren-PetterssonC, et al.Malignancy in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Am J Med Genet A. 2006;140(8):906–909. doi:https://doi.org/10.1002/ajmg.a.31199
49.
VeerapandiyanAChinnIKSchochKMaloneyKAShashiV. Reactive lymphoid hyperplasia in association with 22q11.2 deletion syndrome and a BRCA2 mutation. Eur J Med Genet. 2011;54(1):63–66. doi:https://doi.org/10.1016/j.ejmg.2010.09.004
50.
SoaresDCDantasAGMattaMC, et al.Lymphoproliferative disorder with polyautoimmunity and hypogammaglobulinemia: An unusual presentation of 22q11.2 deletion syndrome. Clin Immunol. 2020;220:108590. doi:https://doi.org/10.1016/j.clim.2020.108590
51.
NiklassonLRasmussenPÓskarsdóttirSGillbergC. Attention deficits in children with 22q.11 deletion syndrome. Dev Med Child Neurol.2005;47(12):803–807. doi:https://doi.org/10.1017/S0012162205001702
BakerKDSkuseDH. Adolescents and young adults with 22qll deletion syndrome: Psychopathology in an at-risk group. Br J Psychiatry.2005;186(2):115–120. doi:https://doi.org/10.1192/bjp.186.2.115
54.
AntshelKMFremontWRoizenNJ, et al.ADHD, major depressive disorder, and simple phobias are prevalent psychiatric conditions in youth with velocardiofacial syndrome. J Am Acad Child Adolesc Psychiatry.2006;45(5):596–603. doi:https://doi.org/10.1097/01.chi.0000205703.25453.5a
55.
AntshelKMShprintzenRHigginsFWFaraoneAMKatesSVRW. Cognitive and psychiatric predictors to psychosis in velocardiofacial syndrome. J Am Acad Child Adolesc Psychiatry.2010;49(4):333–344. doi:https://doi.org/10.1097/00004583-201004000-00008
56.
StoddardJNiendamTHendrenRCarterCSimonTJ. Attenuated positive symptoms of psychosis in adolescents with chromosome 22q11.2 deletion syndrome. Schizophr Res.2010;118(1):118–121. doi:https://doi.org/10.1016/j.schres.2009.12.011
57.
WallinLGillbergCFernellEGillbergCBillstedtE. Neurodevelopmental and other psychiatric disorders in 22q11.2 deletion syndrome from childhood to adult age: Prospective longitudinal study of 100 individuals. Am J Med Genet C Semin Med Genet. 2023;193(2):172–182. doi:https://doi.org/10.1002/ajmg.c.32052
58.
DanielsonMLBitskoRHGhandourRMHolbrookJRKoganMDBlumbergSJ. Prevalence of parent-reported ADHD diagnosis and associated treatment among U.S. children and adolescents, 2016. J Clin Child & Adolesc Psychol. 2018;47(2):199–212. doi:https://doi.org/10.1080/15374416.2017.1417860
59.
BarbaresiWKatusicSColliganR, et al.How common is attention-deficit/hyperactivity disorder? Towards resolution of the controversy: Results from a population-based study. Acta Paediatr.2004;93(s445):55–59. doi:https://doi.org/10.1111/j.1651-2227.2004.tb03058.x
60.
KoganMDVladutiuCJSchieveLA, et al.The prevalence of parent-reported autism spectrum disorder among US children. Pediatrics. 2018;142(6):e20. doi:https://doi.org/10.1542/peds.2017-4161
61.
MaennerMJWarrenZWilliamsAR, et al.Prevalence and characteristics of autism spectrum disorder among children aged 8 years — autism and developmental disabilities monitoring network, 11 sites, United States, 2020. MMWR Surveill Summ.2023;72(2):1–14. doi:https://doi.org/10.15585/mmwr.ss7202a1
62.
VingerhoetsCvan OudenarenMJFBloemenOJN, et al.Low prevalence of substance use in people with 22q11.2 deletion syndrome. Br J Psychiatry.2019;215(5):661–667. doi:https://doi.org/10.1192/bjp.2018.258
63.
SwillenAMossEDuijffS. Neurodevelopmental outcome in 22q11.2 deletion syndrome and management. Am J Med Genet A.2018;176(10):2160–2166. doi:https://doi.org/10.1002/ajmg.a.38709
64.
AntshelKMHendricksKShprintzenR, et al.The longitudinal course of attention deficit/hyperactivity disorder in velo-cardio-facial syndrome. J Pediatr.2013;163(1):187–193.e1. doi:https://doi.org/10.1016/j.jpeds.2012.12.026
65.
KatesWRMarianoMAAntshelKM, et al.Trajectories of psychiatric diagnoses and medication usage in youth with 22q11.2 deletion syndrome: A 9-year longitudinal study. Psychol Med.2019;49(11):1914–1922. doi:https://doi.org/10.1017/S0033291718002696
66.
SwillenAMcDonald-McGinnD. Developmental trajectories in 22q11.2 deletion syndrome. Am J Med Genetics C: Seminars Med Genetics. 2015;169(2):172–181. doi:https://doi.org/10.1002/ajmg.c.31435
67.
GreenTGothelfDGlaserB, et al.Psychiatric disorders and intellectual functioning throughout development in velocardiofacial (22q11.2 deletion) syndrome. J Am Acad Child Adolesc Psychiatry.2009;48(11):1060–1068. doi:https://doi.org/10.1097/CHI.0b013e3181b76683
68.
ZhaoYGuoTFiksinskiA, et al.Variance of IQ is partially dependent on deletion type among 1,427 22q11.2 deletion syndrome subjects. Am J Med Genet A. 2018;176(10):2172–2181. doi:https://doi.org/10.1002/ajmg.a.40359
69.
FiksinskiAMBeardenCEBassettAS, et al.A normative chart for cognitive development in a genetically selected population. Neuropsychopharmacology (New York, N.Y.). 2022;47(7):1379–1386. doi:https://doi.org/10.1038/s41386-021-00988-6
70.
VorstmanJASBreetveltEJDuijffSN, et al.Cognitive decline preceding the onset of psychosis in patients with 22q11.2 deletion syndrome. JAMA Psychiatry. 2015;72(4):377. doi:https://doi.org/10.1001/jamapsychiatry.2014.2671
71.
GothelfDSchneiderMGreenT, et al.Risk factors and the evolution of psychosis in 22q11.2 deletion syndrome: A longitudinal 2-site study. J Am Acad Child Adolesc Psychiatry.2013;52(11):1192–1203.e3. doi:https://doi.org/10.1016/j.jaac.2013.08.008
72.
NiklassonLRasmussenPÓskarsdóttirSGillbergC. Chromosome 22q11 deletion syndrome (CATCH 22): Neuropsychiatric and neuropsychological aspects. Dev Med Child Neurol.2002;44(1):44–50. doi:https://doi.org/10.1111/j.1469-8749.2002.tb00258.x
73.
ButcherNJBootELangAE, et al.Neuropsychiatric expression and catatonia in 22q11.2 deletion syndrome: An overview and case series. Am J Med Genetics A. 2018;176(10):2146–2159. doi:https://doi.org/10.1002/ajmg.a.38708
74.
PlaksMArgamanRStawskiMQwiatTPolakDGothelfD. Social-sexual education in adolescents with behavioral neurogenetic syndromes. Isr J Psychiatry Relat Sci. 2010;47(2):118–124.
75.
Cortés-MartínJPeñuelaNLSánchez-GarcíaJCMontiel-TroyaMDíaz-RodríguezLRodríguez-BlanqueR. Deletion syndrome 22q11.2: A systematic review. Children (Basel). 2022;9(8):1168. doi:https://doi.org/10.3390/children9081168
76.
PalmerLDMcManusZHeungT, et al.Reproductive outcomes in adults with 22q11.2 deletion syndrome. Genes (Basel). 2022;13(11):2126. doi:https://doi.org/10.3390/genes13112126
77.
CurtinAMannionAShprintzenRJWhelanSCoyneRLeaderG. An examination of adaptive behavior and functional outcomes in adults with 22q11.2 deletion syndrome: A parental perspective. Am J Med Genet A. 2022;188(4):1040–1047. doi:https://doi.org/10.1002/ajmg.a.62604
78.
McDonald-McGinnDMTonnesenMKLaufer-CahanaA, et al.Phenotype of the 22q11.2 deletion in individuals identified through an affected relative: Cast a wide FISHing net!. Genet Med. 2001;3(1):23–29. doi:https://doi.org/10.1097/00125817-200101000-00006
79.
MoshevaMPouillardVFishmanY, et al.Education and employment trajectories from childhood to adulthood in individuals with 22q11.2 deletion syndrome. Eur Child Adolesc Psychiatry. 2019;28(1):31–42. doi:https://doi.org/10.1007/s00787-018-1184-2
80.
MoshevaMEyalSWeismanO, et al.Higher adaptive functioning and lower rate of psychotic comorbidity in married versus unmarried individuals with 22q11.2 deletion syndrome. Am J Med Genet A. 2018;176(11):2365–2374. doi:https://doi.org/10.1002/ajmg.a.38555
81.
Shared decision making.National Institute for Health and Care Excellence (NICE); 2021
82.
CaplesMMcCarthyBSavageE.Hardiness as a resilience factor for adaptation in families of children with 22q11.2 deletion syndrome: A mixed methods study of parents’ perspectives. J Intellect Disabil. 2023;28(3):738-758. doi:https://doi.org/10.1177/17446295231186851
83.
GurREWhiteLKShaniS, et al.A binational study assessing risk and resilience factors in 22q11.2 deletion syndrome. J Psychiatr Res. 2021;138:319–325. doi:https://doi.org/10.1016/j.jpsychires.2021.03.058
84.
WalkowiakDDomaradzkiJ. Parental experiences and needs of caring for a child with 22q11.2 deletion syndrome. Orphanet J Rare Dis. 2023;18(1):379. doi:https://doi.org/10.1186/s13023-023-02980-3
85.
CostainGChowEWCRayPNBassettAS. Caregiver and adult patient perspectives on the importance of a diagnosis of 22q11.2 deletion syndrome. J Intellect Disabil Res. 2012;56(6):641–651. doi:https://doi.org/10.1111/j.1365-2788.2011.01510.x
86.
CosmanTFinlessARideoutAL, et al.An online survey to understand the needs of caregivers of family members with 22q11 deletion syndrome. J Intellect Disabil Res. 2023;67(9):860–868. doi:https://doi.org/10.1111/jir.13061
87.
VoOKMcNeillAVogtKS. The psychosocial impact of 22q11 deletion syndrome on patients and families: A systematic review. Am J Med Genet A. 2018;176(10):2215–2225. doi:https://doi.org/10.1002/ajmg.a.38673
88.
WhitePSchmidtAShorrJIlangoSBeckDMcManusM.SixCore Elements of Health Care Transition™ 3.0. Got Transition, The National Alliance to Advance Adolescent Health; 2020
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
